Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRTX Vertex Pharmaceuticals Inc
$472.34 -0.95% -4.55
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 122.3B
Enterprise value 116.5B
Trailing PE 33.55665
Forward PE 23.599318
PEG Ratio 7.152864868421
Enterprise to EBITDA 24.732
Enterprise to revenue 9.94
Price to book MRQ 6.9920964
Price to sales TTM 10.4285755

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 11.7B
EBITDA 485.8M
Diluted EPS TTM 14.21
Total Cash (MRQ) 6.3B
Current ratio (MRQ) 2.362
Operating Cash Flow (TTM) 3.7B

VRTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.